GlassScriptPhysician profile
Jeffrey M Roth
NPI 1437196631
$748.91
in general payments reported to CMS, 2019-2025
15 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.98 · 2020: $35.92 · 2021: $47.86 · 2022: $63.19 · 2023: $125 · 2024: $84.07 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $197.13 | 2020-2025 | Rocklatan, Eysuvis, Simbrinza |
| Sun Pharmaceutical Industries INC. | $101.95 | 2019-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $65.57 | 2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $54.00 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $51.58 | 2023-2024 | |
| Oyster Point Pharma, INC. | $48.42 | 2022-2025 | Ryzumvi, Tyrvaya |
| Bausch & Lomb Americas INC. | $39.03 | 2022-2025 | Miebo, Xiidra |
| Abbvie INC. | $34.13 | 2025 | |
| Novartis Pharmaceuticals Corporation | $31.01 | 2021 | |
| Amgen INC. | $28.61 | 2025 | Tepezza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $27.23 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Harrow Eye, LLC | $17.89 | 2025 | Vevye |
| Biotissue Holdings INC. | $16.85 | 2021 | |
| Rxsight INC | $16.11 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Light Adjustable Lens (Rxlal) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.